4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and metformin

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with metformin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dennis, PA; Fox, SD; Kawabata, S; Maier, CR; Memmott, RM; Mercado, JR	1
Dallos, M; Dennis, PA; Gills, JJ; Hollander, MC; Kitagawa, H; Kunnumakkara, AB; Memmott, RM; Quinn, BJ	1
Ahmed, H; Al-Bayedh, SA; Qudsi, M; Rahim, MM; Roos, JF; Samara, A	1

Reviews

1 review(s) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and metformin

Article	Year
Metformin for lung cancer prevention and improved survival: a novel approach. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2019, Volume: 28, Issue:4 Topics: Carcinogenesis; Carcinogens; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Incidence; Lung; Lung Neoplasms; Metformin; Nicotiana; Nitrosamines; Signal Transduction; Smoke; Survival Analysis; Tobacco Smoking; TOR Serine-Threonine Kinases	2019

Article

Year

Metformin for lung cancer prevention and improved survival: a novel approach.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2019, Volume: 28, Issue:4

Topics: Carcinogenesis; Carcinogens; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Incidence; Lung; Lung Neoplasms; Metformin; Nicotiana; Nitrosamines; Signal Transduction; Smoke; Survival Analysis; Tobacco Smoking; TOR Serine-Threonine Kinases

2019

Other Studies

2 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and metformin

Article	Year
Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:9 Topics: Adenylate Kinase; Administration, Oral; Animals; Antineoplastic Agents; Carcinogens; Carcinoma; Drug Evaluation, Preclinical; Female; Hypoglycemic Agents; Injections, Intraperitoneal; Lung Neoplasms; Metformin; Mice; Nicotiana; Nitrosamines; Signal Transduction; TOR Serine-Threonine Kinases	2010
Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling. Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:8 Topics: AMP-Activated Protein Kinases; Animals; Carcinogens; Cell Transformation, Neoplastic; Energy Metabolism; Enzyme-Linked Immunosorbent Assay; Female; Hypoglycemic Agents; Insulin-Like Growth Factor I; Lung Neoplasms; Male; Metformin; Mice; Mice, Inbred A; Mice, Knockout; Nitrosamines; Phosphorylation; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tissue Distribution	2013

Article

Year

Metformin prevents tobacco carcinogen--induced lung tumorigenesis.

Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:9

Topics: Adenylate Kinase; Administration, Oral; Animals; Antineoplastic Agents; Carcinogens; Carcinoma; Drug Evaluation, Preclinical; Female; Hypoglycemic Agents; Injections, Intraperitoneal; Lung Neoplasms; Metformin; Mice; Nicotiana; Nitrosamines; Signal Transduction; TOR Serine-Threonine Kinases

2010

Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:8

Topics: AMP-Activated Protein Kinases; Animals; Carcinogens; Cell Transformation, Neoplastic; Energy Metabolism; Enzyme-Linked Immunosorbent Assay; Female; Hypoglycemic Agents; Insulin-Like Growth Factor I; Lung Neoplasms; Male; Metformin; Mice; Mice, Inbred A; Mice, Knockout; Nitrosamines; Phosphorylation; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tissue Distribution

2013